○イチョウ葉エキス(EGb-761)は脳血管や中枢神経系にたいして有益な効果があるとする研究論文が多数ある.そのうち,イチョウ葉エキスのEGb-761が示す虚血・再潅流による認知機能ダメージに対する回復効果には,イチョウ葉に含まれるginkgolide BのPAF receptorに対するアンタゴニストとしての作用が関与している可能性が考えられるという(Maclennan K., et al. (2002) , Prog. Neurobiol., 67: 235).○さらに,イチョウ葉エキスはlong-term treatment(おおよそ27日から二ヶ月;Burnello N. et al. (1985), Pharmacol. Res. Commun. 17: 1063-1072)とshort-term treatment(7日間:Ch. I.Hadjiivanova and V. V. Petkov (2002), Phytother. Res. 16, 488-490)いずれの経口投与においても前頭葉皮質と海馬におけるβadrenoreceptorの発現数が抑えられ,学習と記憶のレベルが増加する.一方,イチョウの果皮は接触性皮膚炎を誘発することで有名である.皮膚炎誘発物質はginkgolic acidsとこれに関連するalkylphenol類によるが,EGb-761に混入するこの物質の限界値は5 ppmとされる.この物質は神経系に対してアポトーシスを誘導し,そのメカニズムはprotein phosphatase 2Cの活性化による(Ahlemeyer B. (2001), Eur. J. Pharmacol. 430: 1-7).
参考文献 1. Cesarani A, Meloni F, Alpini D, Barozzi S, Verderio L, Boscani PF.
Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. Adv. Ther., 15: 291-304, 1998. [PMID: 10345150]
2. De Smet PA. Herbal remedies.
N. Engl. J. Med., 347: 2046-2056, 2002. [PMID: 12490687]
3. Ernst E.
The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.
Ann. Intern. Med., 136: 42-53, 2002. [PMID: 11777363]
4. The Complete German Commission E Monographs, The American Botanical Council, ISBN 0-9655555-0-X
5. Akiba S, Kawauchi T, Oka T, Hashizume T, Sato T.
Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation.
Biochem. Mol. Biol. Int., 46: 1243-1248, 1998. [PMID: 9891858]
6. Oyama Y, Fuchs PA, Katayama N, Noda K.
Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons.
Brain Res., 635: 125-129, 1994. [PMID: 8173947]
7. Rong Y, Geng Z, Lau BH.
Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells.
Free Radic. Biol. Med., 20 121-127, 1996. [PMID: 8903688]
8. Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L.
Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
Biochem. Pharmacol., 36: 2749-2752, 1987. [PMID: 2820421]
9. Braquet P, Hosford D.
Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.
J. Ethnopharmacol., 32: 135-139, 1991. [PMID: 1881152]
10. Yan LJ, Droy-Lefaix MT, Packer L.
Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper.
Biochem. Biophys. Res. Commun., 212: 360-366, 1995. [PMID: 7626049]
11. Iliff LD, Auer LM.
The effect of intravenous infusion of Tebonin (Ginkgo biloba) on pial arteries in cats.
J. Neurosurg. Sci., 27: 227-231, 1983. [PMID: 6674418]
12. Umegaki K, Shinozuka K, Watarai K, Takenaka H, Yoshimura M, Daohua P, Esashi T.
Ginkgo biloba extract attenuates the development of hypertension in deoxycorticosterone acetate-salt hypertensive rats.
Clin. Exp. Pharmacol. Physiol., 27: 277-282, 2000. [PMID: 10779125]
13. Rapin JR, Yoa R, Bouvier C, Drieu K.
Effect of repeated treatments with an extract of Ginkgo biloba (EGb761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat.
Drug Dev. Res., 40: 68-74, 1997. [PMID: 2947087]
14. McKenna DJ, Jones K, Hughes K.
Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.
Altern. Ther. Health Med., 7: 70-86, 88-90, 2001. [PMID: 11565403]
15. Wettstein A.
Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.
Phytomedicine, 6: 393-401, 2000. [PMID: 10755847]
16. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF.
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
JAMA, 278: 1327-1332, 1997. [PMID: 9343463]
17. Le Bars PL, Kieser M, Itil KZ.
A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
Dement. Geriatr. Cogn. Disord., 11: 230-237, 2000. [PMID: 10867450]
18. Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R.
Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Pharmacopsychiatry, 29: 47-56, 1996. [PMID: 8741021]
19. Kleijnen J, Knipschild P.
Ginkgo biloba for cerebral insufficiency.
Br. J. Clin. Pharmacol., 34: 352-358, 1992. [PMID: 1457269]
20. Hindmarch I.
Activity of Ginkgo biloba extract on short-term memory.
Presse Med., 15: 1592-1594, 1986. [PMID: 2947108]
21. Ernst E, Stevinson C.
Ginkgo biloba for tinnitus: a review.
Clin. Otolaryngol., 24: 164-167, 1999. [PMID: 10384838]
22. Peters H, Kieser M, Holscher U.
Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Vasa., 27: 106-110, 1998. [PMID: 9612115]
23. Pittler MH, Ernst E.
Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.
Am. J. Med., 108: 276-281, 2000. [PMID: 11014719]
24. De Backer TL, Vander Stichele RH, Warie HH, Bogaert MG.
Oral vasoactive medication in intermittent claudication: utile or futile? Eur. J. Clin. Pharmacol., 56:199-206, 2000. [PMID: 10952473]
25. Cohen AJ, Bartlik B.
Ginkgo biloba for antidepressant-induced sexual dysfunction.
J. Sex. Marital Ther., 24: 139-143, 1998. [PMID: 9611693]
26. Mossabeb R, Kraft D, Valenta R.
Evaluation of the allergenic potential of Ginkgo biloba extracts.
Wien Klin. Wochenschr., 113: 580-587, 2001. [PMID: 11571835]
27. Izzo AA, Ernst E.
Interactions between herbal medicines and prescribed drugs: a systematic review.
Drugs, 61: 2163-2175, 2001. [PMID: 11772128]
28. Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB.
Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba.
J. Neurol. Neurosurg. Psychiatry, 68: 679-680, 2000. [PMID: 10836866]
29. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH.
St John's Wort: effect on CYP3A4 activity.
Clin. Pharmacol. Ther., 67: 451-457, 2000. [PMID: 10824623]
30. Duche JC, Barre J, Guinot P, Duchier J, Cournot A, Tillement JP.
Effect of Ginkgo biloba extract on microsomal enzyme induction.
Int. J. Clin. Pharmacol. Res., 9: 165-168, 1989. [PMID: 2744909]
31. Shinozuka K, Umegaki K, Kubota Y, Tanaka N, Mizuno H, Yamauchi J, Nakamura K, Kunitomo M.
Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats.
Life Sci., 70: 2783-2792, 2002. [PMID: 12269382]
32. Umegaki K, Saito K, Kubota Y, Sanada H, Yamada K, Shinozuka K.
Ginkgo biloba Extract Markedly Induces Pentoxyresorufin O-Dealkylase Activity in Rats.
Jpn. J. Pharmacol., 90: 345-351, 2002. [PMID: 12501011]